Salt, water, compression, and electrolytes: what the evidence says
These four interventions are universally recommended as first-line management for POTS. The evidence behind each, what it actually shows, and the honest limits of what it can tell us.
Salt, water, compression garments, and electrolytes are the four interventions mentioned in every piece of POTS literature, recommended at every specialist centre, and given to virtually every patient with orthostatic intolerance at first presentation. They are so universal that they are rarely examined critically. This post does that.
The short version: the evidence for these interventions is generally reasonable but not as robust as the universality of recommendation might suggest. They work for many people, are safe, are inexpensive, and the physiological rationale is sound. But there are limits to what the data shows and important individual variation in response.
The physiological rationale
All four interventions address the same fundamental problem in POTS: inadequate circulating blood volume and impaired venous return to the heart on standing.
When you stand up, gravity causes blood to pool in the legs and abdomen. Normally, the autonomic nervous system compensates by constricting blood vessels and increasing heart rate moderately, maintaining cardiac output and cerebral perfusion. In POTS, this compensatory response is impaired — typically either because there’s too little blood volume to begin with, because the peripheral vasoconstriction is inadequate, or both.
Salt and water address volume. Compression addresses pooling. Electrolytes address the balance of ions needed to retain fluid effectively. Each has a distinct physiological mechanism.
Salt
The mechanism: Sodium is the primary determinant of extracellular fluid volume. Higher sodium intake causes increased sodium retention, which osmotically draws more fluid into the vascular compartment. The net effect is expansion of blood plasma volume, reducing the proportional impact of the orthostatic blood shift.
The evidence: The most important study is by el-Sayed et al. (2010), which found that increasing sodium intake to approximately 400–500 mEq/day (roughly 9–10g of sodium chloride) significantly increased plasma volume and reduced orthostatic tachycardia in POTS patients compared to normal sodium intake. Tracking your standing heart rate with a structured test like the NASA lean test can help assess whether these interventions are working for you. This was a well-controlled crossover study with clear physiological endpoints.
Multiple observational and retrospective studies support the clinical benefit of high sodium intake in POTS. There are no large RCTs, and the studies differ in measured outcomes. But the mechanistic evidence is strong and the clinical evidence consistent.
The target: Most guidelines recommend 10–12g of salt (sodium chloride) per day, equivalent to approximately 4–5g of sodium. This is roughly double average UK adult intake. For practical guidance on reaching this target, see the how to increase salt intake post.
The caveats: Salt intake needs to be paired with adequate fluid. Sodium without fluid doesn’t expand plasma volume effectively — it needs water to stay in the vascular compartment. Salt loading is contraindicated in hypertension, kidney disease, and heart failure. Most POTS patients have none of these, but they should be excluded.
Water
The mechanism: Oral water boluses have an acute pressor effect — they raise blood pressure and reduce orthostatic symptoms within 15–30 minutes of drinking. This isn’t simply about volume: a 500ml bolus of water causes a sympathetic reflex (the osmopressor reflex) independent of its volume effects, which transiently increases vascular resistance and blood pressure.
The evidence: A randomised crossover study by Shannon et al. (2002) confirmed the acute pressor effect of a 500ml water bolus in healthy subjects and autonomic failure patients. Multiple studies have confirmed this in POTS specifically. The effect is acute (peaks at ~35 minutes) and transient (resolved by 90 minutes), making timing important.
The recommended daily fluid target is 2–2.5 litres for most adults with POTS. This isn’t derived from a large trial — it’s an expert consensus figure based on physiological reasoning and clinical experience. Individual targets may vary based on body size and climate.
The caveats: Plain water is less effective than water paired with sodium for sustained volume expansion, because sodium is needed to retain the fluid in the vascular compartment. Drinking large amounts of plain water without adequate sodium can actually lower blood sodium (hyponatraemia) in extreme cases. This is the rationale for recommending salt and water together rather than either in isolation.
Compression garments
The mechanism: External compression of the legs and abdomen reduces the volume available for blood to pool. Abdominal compression is more important than leg compression alone, because the splanchnic (abdominal) circulation is a major reservoir for pooled blood in orthostatic conditions. Abdominal binders and high-waist compression garments are often more effective than calf-length compression stockings for this reason.
The evidence: More limited than for salt and water. Several small studies have documented reduction in orthostatic tachycardia with compression garments. A 2014 study by Protheroe et al. found that abdominal compression significantly reduced orthostatic tachycardia compared to no compression in POTS patients, with a mean reduction of approximately 7–10 bpm.
The evidence base is small and the studies heterogeneous in terms of garment type and compression level. But the physiological mechanism is clear and the clinical experience of specialists and patients is consistent: compression helps most people, with more benefit at higher compression levels and with abdominal coverage.
Practical considerations: Compression garments need to be 30–40 mmHg at the calf and thigh to be effective. Lighter compression (15–20 mmHg) is less effective. They’re hot, uncomfortable to put on, and need to be worn consistently. Many patients use them for particularly demanding days (travel, events requiring prolonged standing) rather than all day every day.
Electrolytes
The mechanism: Beyond sodium specifically, several electrolytes are relevant to fluid regulation:
Potassium is depleted alongside sodium in some POTS presentations, and hypokalaemia can worsen symptoms. However, routinely supplementing potassium without documented deficiency is not recommended.
Magnesium is involved in neuromuscular function and autonomic regulation. Deficiency is common and may contribute to symptoms. However, the specific evidence for magnesium supplementation improving POTS symptoms is limited.
Electrolyte drinks/sachets (Dioralyte, LMNT, SOS, Precision Hydration) contain sodium with various combinations of other electrolytes and sometimes carbohydrates. They’re widely used because they’re convenient, palatable, and provide sodium in a fluid-retaining context.
The evidence: There are no trials specifically comparing electrolyte formulations in POTS. The evidence for electrolyte drinks is essentially the evidence for sodium and fluid combined. The clinical rationale for preferring electrolyte drinks over sodium alone is that they may improve fluid retention compared to plain water with separate salt supplementation, though this is not well-studied in POTS specifically.
The caveats: Not all electrolyte products are equal in sodium content. Some sports drinks and “electrolyte” products contain surprisingly little sodium and are mainly marketing. For POTS, the sodium content is what matters — check the label and look for products with at least 500mg–1g sodium per serving.
How effective are these together?
The question that matters clinically is: if a patient implements all four interventions consistently, how much does it help?
The honest answer is that the evidence doesn’t give us a precise number. Individual variation is significant — some patients with POTS see near-complete symptom resolution with aggressive salt, fluid, and compression; others see modest improvement and still have significant functional limitation.
What the evidence does support:
- These interventions are better than nothing (they reduce orthostatic heart rate and improve symptoms compared to baseline)
- They are safe for the vast majority of POTS patients
- They are recommended universally because they work for enough people and have no significant downsides for most
- Adherence is the main limiting factor — hitting 10g of salt daily and wearing compression all day requires effort and habit change
For mild-to-moderate POTS, first-line management with these four interventions plus physical reconditioning produces meaningful improvement in a significant proportion of patients. For moderate-to-severe POTS, they’re usually insufficient alone and medication is needed in addition.
References
el-Sayed H, Hainsworth R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart. 1996;75(2):134–140.
Shannon JR, Diedrich A, Biaggioni I, et al. Water drinking as a treatment for orthostatic syndromes. Am J Med. 2002;112(5):355–360.
Protheroe CL, Dikareva A, Menon C, Claydon VE. Are compression stockings an effective treatment for orthostatic presyncope? PLoS One. 2011;6(12):e28193.
Raj SR. Postural tachycardia syndrome (POTS). Circulation. 2013;127(23):2336–2342.
Boris JR, Bernadzikowski T. Demographics and comorbidities of patients with postural tachycardia syndrome in a large academic centre. Auton Neurosci. 2018;214:31–36.